Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

SIMPLE SUMMARY: Active therapeutic options in advanced soft tissue sarcoma (STS), able to induce durable objective responses, are limited beyond first-line chemotherapy. Although results obtained in clinical trials suggest there is a high probability for patients with STS to benefit from treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Grünwald, Viktor, Pink, Daniel, Egerer, Gerlinde, Schalk, Enrico, Augustin, Marinela, Deinzer, Christoph K. W., Kob, Viola, Reichert, Dietmar, Kebenko, Maxim, Brandl, Stephan, Hahn, Dennis, Lindner, Lars H., Hoiczyk, Mathias, Ringsdorf, Uta, Hanker, Lars C., Hempel, Dirk, De Rivas, Beatriz, Wismann, Tobias, Ivanyi, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653615/
https://www.ncbi.nlm.nih.gov/pubmed/36358652
http://dx.doi.org/10.3390/cancers14215234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653615/
https://www.ncbi.nlm.nih.gov/pubmed/36358652
http://dx.doi.org/10.3390/cancers14215234

Ejemplares similares